Baker Bros. Advisors LP Compass Therapeutics, Inc. Transaction History
Baker Bros. Advisors LP
- $9.34 Billion
- Q3 2024
A detailed history of Baker Bros. Advisors LP transactions in Compass Therapeutics, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 1,557,630 shares of CMPX stock, worth $2.15 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,557,630
Previous 1,557,630
-0.0%
Holding current value
$2.15 Million
Previous $1.56 Million
84.07%
% of portfolio
0.03%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding CMPX
# of Institutions
79Shares Held
91.9MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$30.9 Million0.97% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$15.4 Million0.04% of portfolio
-
Blackstone Inc New York, NY10MShares$13.8 Million0.09% of portfolio
-
Black Rock Inc. New York, NY6.61MShares$9.13 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA5.64MShares$7.79 Million1.62% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $140M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...